Target intelligence / Profile preview

Histone H1.10 (H1-10)

Target
H1-10
Molecular classification
Histone, Linker histone, Chromatin architectural protein, Other
01

Overview

Histone H1.10 is a replication-independent linker histone variant, encoded by the H1-10 (H1FX) gene, and is a member of the histone H1 family[4]. It acts as a chromatin architectural protein by binding to linker DNA between nucleosomes and promoting condensation of nucleosome arrays into higher-order chromatin structures[1][2][3][4][5]. Unlike core histones (H2A, H2B, H3, H4), H1.10 does not form part of the nucleosome "bead," but stabilizes the overall chromatin fiber, regulates DNA accessibility, and thereby modulates gene expression, nucleosome spacing, and chromatin folding[2][3][4]. H1.10 is predominantly expressed in differentiated cells and is considered critical for maintaining genome organization, epigenetic state, and cellular identity[2][4][5]. No drugs are known to specifically target Histone H1.10, and its direct use as a therapeutic target or biomarker is currently not established. Disruption of H1 variants, including H1.10, can significantly impact global chromatin condensation and gene regulation[5]. Key post-translational modifications (e.g., phosphorylation, acetylation, methylation) regulate its chromatin binding dynamics and function[2][5].

Other names
H1.10 linker histoneH1FXH1XHistone H1xhistone H1xH1 histone family member XMGC15959MGC8350
02

Biological functions

Chromatin compactionRegulation of gene expressionNucleosome spacingChromosome structure stabilizationHigher-order chromatin foldingRegulation of DNA accessibilityModulation of protein recruitment to chromatinTranscription regulation
03

Disease associations

Cancer (altered expression or distribution implicated in several cancers)Other (evidence for roles in cell differentiation, but direct links to disease phenotypes are limited)
04

Safety considerations

Targeting histones could have profound effects on global chromatin structure and genome stabilityPossible widespread gene dysregulation if perturbed

Beyond the preview

Go deeper on Histone H1.10 (H1-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H1.10 (H1-10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call